Frank Rimerman Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Sell |
32,079
-685
| -2% | -$75.9K | 0.24% | 66 |
|
|
2025
Q1 | $3.67M | Buy |
32,764
+446
| +1% | +$50K | 0.29% | 53 |
|
|
2024
Q4 | $2.99M | Buy |
32,318
+232
| +0.7% | +$21.4K | 0.22% | 72 |
|
|
2024
Q3 | $2.69M | Buy |
32,086
+2,252
| +8% | +$189K | 0.19% | 90 |
|
|
2024
Q2 | $2.05M | Buy |
29,834
+29,185
| +4,497% | +$2M | 0.14% | 116 |
|
|
2024
Q1 | $47.5K | Buy |
649
+208
| +47% | +$15.2K | 0.01% | 129 |
|
|
2023
Q4 | $35.7K | Buy |
+441
| New | +$35.7K | 0.01% | 130 |
|